Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow (BM)-derived cells are key players in atherogenesis but whether Ang II induces plaque vulnerability directly through Ang II type 1 receptor (AT1R) activation on these cells remains to be clarified. In the present study, we investigated whether a lack of AT1R on BM-derived cells might affect Ang II-mediated vulnerable plaque development. The 2-kidney, 1-clip (2K1C) model (Ang II-dependent mouse model of advanced atherosclerosis and vulnerable plaques) was generated in ApoE−/− mice transplanted with AT1aR−/− or AT1aR+/+ BM. Plasma cholesterol as well as hepatic mRNA expression levels of genes involved in cholesterol metabolism were...
Mechanisms responsible for atherosclerotic plaque development, destabilization, and rupture are stil...
Objective—Although vascular smooth muscle cells (VSMCs) provide the major structural integrity of at...
Objectives—Angiotensin II (ATII) type 1 receptor (AT1R) blocker (ARB) has been shown to inhibit neoi...
Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow (BM)-derive...
Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow (BM)-derive...
Local hematopoietic bone marrow (BM) renin-angiotensin system (RAS) affects the growth, production, ...
bone marrow; renin Angiotensin II (Ang II) has long been considered the ma-jor bioactive effector mo...
Background—Hypercholesterolemia-induced atherosclerosis is attenuated by either pharmacological anta...
Whole body genetic deletion of AT1a receptors in mice uniformly reduces hypercholesterolemia and ang...
BackgroundWe explored the role of angiotensin II in determining the histomorphometric features of pl...
Abstract—Activation of type 1 angiotensin (AT1) receptors causes hypertension, leading to progressiv...
Background: Angiotensin II (AngII), the main bioactive peptide of the renin angiotensin system, exer...
Background and aims Angiotensin II (Ang II) infusion promotes the development of aortic aneurysms an...
Angiotensin II (AngII), the main bioactive peptide of the renin angiotensin system, exerts most of i...
International audienceAims The angiotensin II type 1 receptor (AT1R) through the activation of immun...
Mechanisms responsible for atherosclerotic plaque development, destabilization, and rupture are stil...
Objective—Although vascular smooth muscle cells (VSMCs) provide the major structural integrity of at...
Objectives—Angiotensin II (ATII) type 1 receptor (AT1R) blocker (ARB) has been shown to inhibit neoi...
Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow (BM)-derive...
Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow (BM)-derive...
Local hematopoietic bone marrow (BM) renin-angiotensin system (RAS) affects the growth, production, ...
bone marrow; renin Angiotensin II (Ang II) has long been considered the ma-jor bioactive effector mo...
Background—Hypercholesterolemia-induced atherosclerosis is attenuated by either pharmacological anta...
Whole body genetic deletion of AT1a receptors in mice uniformly reduces hypercholesterolemia and ang...
BackgroundWe explored the role of angiotensin II in determining the histomorphometric features of pl...
Abstract—Activation of type 1 angiotensin (AT1) receptors causes hypertension, leading to progressiv...
Background: Angiotensin II (AngII), the main bioactive peptide of the renin angiotensin system, exer...
Background and aims Angiotensin II (Ang II) infusion promotes the development of aortic aneurysms an...
Angiotensin II (AngII), the main bioactive peptide of the renin angiotensin system, exerts most of i...
International audienceAims The angiotensin II type 1 receptor (AT1R) through the activation of immun...
Mechanisms responsible for atherosclerotic plaque development, destabilization, and rupture are stil...
Objective—Although vascular smooth muscle cells (VSMCs) provide the major structural integrity of at...
Objectives—Angiotensin II (ATII) type 1 receptor (AT1R) blocker (ARB) has been shown to inhibit neoi...